The global glycated albumin assay market is projected to reach USD 0.3 billion by 2028 from USD 0.2 billion in 2023, at a CAGR of 8.9% during the forecast period. Growth in the glycated albumin assay market is mainly driven by factors such as the rising prevalence of diabetes and increasing government focus on disease diagnosis.